EVAR with No Complications in Octogenarians: Survival Rate Identical to that of Healthy Octogenarians

This analysis reports (for the first time in the literature) that after the endovascular aortic aneurysm repair (EVAR) in octogenarians, survival rate is the same as that of their healthy counterparts.  

Pacientes que no siguen nuestro consejo y sorpresivamente tienen menos eventos

This is true provided the procedure does not present complications. If any, mortality results twice as high in this group. 

Using propensity score, researchers compared octogenarians with identical comorbidities undergoing EVAR vs. others with no aortic aneurysm from the Rotterdam study.

Complications rate for this procedure resulted 27% (mainly cardiac, pulmonary and access complications). This represents twice as many complications than in younger patients, which emphasizes the importance of correct patient selection.


Read also: Another Scandal in Evidence-Based Medicine: Ambulatory BP Monitoring Questioned?


After uncomplicated EVAR, mortality results similar vs the control group in the Rotterdam trial (HR 1.09, CI 95% 0.68 to 1.77). However, should there be any complications, these figures would see a dramatic change (HR 1.93, CI 95% 1.06 to 3.54).

Conclusion

After uncomplicated EVAR in 80+ patients, survival rate is the same as their healthy contemporaries. 

Patient selection and perioperatory care should be carried out thoroughly. 

Original Title: Survival After Uncomplicated EVAR in Octogenarians is Similar to the General Population of Octogenarians Without an Abdominal Aortic Aneurysm.

Reference: Oscar L. Rueda-Ochoa et al. Eur J Vasc Endovasc Surg, article in press.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Supera vs. Eluvia at 3 Years in Severely Calcified Femoropopliteal Lesions

Severe calcification remains one of the main predictors of restenosis and the need for repeat revascularization following endovascular treatment of femoropopliteal disease. In this...

Is abdominal aortic aneurysm screening cost-effective in women?

Although ultrasound screening for abdominal aortic aneurysm (AAA) is a well-established strategy in men over 65 years of age, its value in women remains...

Aneurysm Sac Regression Predicts Better Clinical Outcomes After EVAR?

Aneurysm sac regression following endovascular abdominal aortic aneurysm repair (EVAR) has been proposed as a marker of favorable remodeling and effective aneurysm exclusion. However,...

SPYRAL Program: 3-Year Outcomes in Patients Treated with Renal Denervation

Hypertension is the leading modifiable risk factor for cardiovascular disease and remains a major global health challenge, affecting more than one billion adults worldwide.  Despite...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

SAFE-PROTECT at 12 Months: AnchorMan vs. Watchman for Left Atrial Appendage Closure

Percutaneous left atrial appendage (LAA) closure is an alternative therapeutic strategy for reducing the risk of stroke in patients with atrial fibrillation (AF). Randomized...

Clinical and haemodynamic outcomes with contemporary intra- vs. supra-annular valves: The HERA-TAVI Registry

According to the latest European guidelines, transcatheter aortic valve implantation (TAVI) is the recommended treatment for patients aged ≥70 years with symptomatic severe aortic...

Redo-TAVI with SAPIEN 3: 30-Day Outcomes

The indications for transcatheter aortic valve implantation (TAVI) have rapidly expanded to include intermediate- and low-risk patients, extending its use to younger individuals with...